سعر بيدريمين Bedremine‏ 100مجم 30 قرص 2026

Bedremine 100Mg 30 Exten. Rel. Tab (30 extended-release tablets), antidepressant marketed in Egypt by Mash Premiere.

• Hypersensitivity to desvenlafaxine, venlafaxine or excipients; use with MAOIs for psychiatric disorders or within 7 days of stopping desvenlafaxine, or within 14 days of stopping an MAOI; starting in patients on linezolid or IV methylene blue.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: increased risk of suicidal thoughts and behaviors in pediatric and young adult patients. Also serotonin syndrome, elevated blood pressure, increased bleeding risk, angle-closure glaucoma, activation of mania, discontinuation syndrome, seizure and hyponatremia.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Monoamine oxidase inhibitors (incl. linezolid, IV methylene blue)Contraindicated: risk of serotonin syndrome.DailyMed (U.S. National Library of Medicine)
• Aspirin, NSAIDs, warfarin and other anticoagulants/antiplateletsIncreased risk of bleeding.DailyMed (U.S. National Library of Medicine)

• SNRI exposure, particularly in the month before delivery, is associated with a less than 2-fold increased risk of postpartum hemorrhage; third-trimester exposure may cause neonatal complications. A pregnancy exposure registry exists.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Limited data show low levels of desvenlafaxine in human milk without adverse reactions reported in breastfed infants; weigh benefits of breastfeeding against maternal need.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Desvenlafaxine: Selective inhibitor of serotonin and norepinephrine reuptake in the CNS (major active metabolite of venlafaxine).